510(k) vs PMA: Choosing the US Regulatory Pathway

Choosing between the FDA’s 510(k) and PMA pathways is the first regulatory decision a medical device seller makes for the US market, and the wrong reading costs six figures and a year. The pathway is set by device classification, which is set by what the device does and the risk it carries, not by the seller’s preference. Hospital furniture and operating room equipment lines mostly travel the shorter road; this comparison explains both roads, the evidence each demands, and how a Chinese manufacturer supports either one.

510(k): Proving Substantial Equivalence

The 510(k) is a premarket notification demonstrating that a device is substantially equivalent to a legally marketed predicate device. Most Class II devices clear this way, and the hospital equipment categories OR buyers source, operating tables, surgical lights, medical pendants, hospital beds and trolleys, generally sit in classifications that reach the US market through this route. The submission compares the new device to a predicate on intended use, technology and performance, supported by bench testing to recognized standards: the IEC 60601 series for electrical safety and EMC is the workhorse evidence set for powered equipment.

What a 510(k) requires from the manufacturer: a device listing and registration, quality system compliance under the FDA’s regulation for device manufacturing, and performance data showing equivalence. What it does not require is the clinical trial program a PMA demands, which is why the 510(k) route typically runs months rather than years for well-documented product families.

PMA: Premarket Approval for the Highest-Risk Devices

The PMA is the FDA’s premarket approval for Class III devices, products that sustain life, are implanted, or carry potential unreasonable risk of illness or injury where general and special controls cannot assure safety. A PMA application carries engineering, laboratory and clinical evidence reviewed at a depth closer to a drug application, with manufacturing inspection as part of the process. Implants, defibrillators and high-risk life-support devices travel this road.

Hospital furniture and OR equipment sellers rarely enter PMA territory, and pretending otherwise inflates compliance budgets. The relevant planning question runs the other way: as a product line adds electronics, software and patient-connectivity features, classification can shift, and the classification conversation belongs before product development hardens the design. The FDA’s device databases and classification records, published through the eCFR’s Title 21, Food and Drugs, are the primary source a regulatory consultant uses to fix a product’s class and pathway.

What Each Pathway Means for a Buyer Sourcing From China

A US buyer’s compliance exposure differs by pathway, and the factory’s supporting role differs with it. On the 510(k) track, buyers should confirm the manufacturer’s FDA establishment registration, device listing for the product family, quality system certification and the IEC 60601 test reports that feed the submission or the buyer’s own filings. Sanyang Medical’s certification base, CE marking under ISO 13485 quality management and ISO 9001, plus IEC 60601-series testing on powered equipment, maps onto the evidence structure US importers need, and the certificate mapping method for tenders is the same one described in our guide to the tender compliance matrix.

Buyers entering regulated markets beyond the US should note the pattern repeats: registration dossiers in India run through CDSCO’s Class A and B import registration, covered in our guide to CDSCO import registration, and Nigeria’s NAFDAC process is documented in our NAFDAC registration guide. The discipline is identical: classify the device, read the pathway, assemble the evidence.

Foire aux questions